Colon cancer is a common disease internationally. Outcomes have not improved to the same degree as in rectal cancer, where the focus on total mesorectal excision and pathological feedback has significantly contributed to improved survival and reduced local recurrence. Colon cancer surgery shows significant variation around the world, with differences in mesocolic integrity, height of the vascular ligation and length of the bowel resected. This leads to variation in well-recognised quality measures like lymph node yield. Pathologists are able to assess all of these variables and are ideally placed to provide feedback to surgeons and the wider multidisciplinary team to improve surgical quality over time. With a move towards complete mesocolic excision with central vascular ligation to remove the primary tumour and all mechanisms of spread within an intact package, pathological feedback will be central to improving outcomes for patients with operable colon cancer. This review focusses on the key quality measures and the evidence that underpins them.
结肠癌是一种全球性常见疾病。其治疗效果改善程度不及直肠癌，后者通过全直肠系膜切除术及病理学反馈显著提升了生存率并降低了局部复发率。全球范围内结肠癌手术存在显著差异，主要体现在系膜完整性、血管结扎高度及肠段切除长度等方面。这种差异导致淋巴结获取数量等公认质量指标存在波动。病理学家能够评估所有这些变量，并处于理想位置为外科医生及更广泛的多学科团队提供反馈，从而持续提升手术质量。随着完整结肠系膜切除联合中央血管结扎术的推广——该术式旨在完整切除原发肿瘤及所有扩散途径——病理学反馈将成为改善可手术结肠癌患者预后的核心环节。本综述重点探讨关键质量指标及其循证依据。
肿瘤(癌症)患者之家